4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-26-022631
Chief Financial Officer gave up 507 shares (to pay taxes)
- Chief Financial Officer acquired 1,228 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Vu Quan Anh · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-30 | Exercise or conversion : show line 1 in the form | +1,228 | 2,728 | D | ||
| 2026-06-30 | Shares withheld for taxes : show line 2 in the form | −507 | $92.59 | $46,943 | 2,221 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-30 | Exercise or conversion : show line 3 in the form Restricted Stock Unit | −1,228 | 8,598 | D |
Loading xslF345X06/rdgdoc.xml…